Patents
Literature
Patsnap Eureka AI that helps you search prior art, draft patents, and assess FTO risks, powered by patent and scientific literature data.

50 results about "Virusoid" patented technology

Virusoids are circular single-stranded RNA(s) dependent on viruses for replication and encapsidation. The genome of virusoids consist of several hundred nucleotides and does not code for any proteins. In humans, the hepatitis D virus is a virusoid capable of causing pathology when in the presence of the hepatitis B virus.

Novel coronavirus nucleic acid pseudovirus standard substance for detection and preparation method thereof

The invention relates to a pseudovirus standard substance for nucleic acid detection of a novel coronavirus (2019-nCoV or called SARS-CoV-2) and a preparation method of the pseudovirus standard substance. Novel coronavirus nucleic acid is integrated into a lentiviral expression plasmid vector, then constructed lentiviral expression plasmids and packaging plasmids are jointly transfected into cells, and a large number of pseudoviral particles packaged with novel coronavirus RNA are obtained after cell expression. After plasmid DNA is removed through DNase I digestion and sucrose density gradient ultracentrifugation, freeze drying is performed to obtain a pseudovirus particle freeze-dried product. The pseudovirus standard substance has the partial RNA sequence packaged with the virus and also has a pseudovirus standard substance packaged with all the sequences, can completely simulate the whole process of virus RNA extraction and nucleic acid detection, and can be used for the verification evaluation and the laboratory quality control of the novel coronavirus nucleic acid qualitative and quantitative detection method. The obtained standard substance has the characteristics of high purity, good safety, accurate quantity value and the like, is good in stability, can be transported at normal temperature, and provides guarantee for quantity value traceability and transmission of thestandard substance.
Owner:NAT INST OF METROLOGY CHINA

Detection of viral vector gene therapy medicament infection titre by applying flow cytometry

The invention discloses a method for using flow cytometry to check the virus carrier gene treatment drug infection, comprising: establishing a mathematic mode which can simulate the character that virus infects cells and is based on poisson distribution, and determining a relative calculation time. The method comprises the steps of: laying cells on a six-hole plate, after the full growth of the cells, selecting a hole and counting, the virus infects the cells, cultivating for a period and digesting, collecting the cells, fixing, permeating and sealing the collected cells, resisting incubation, and the secondly resisting incubation marked by FITC, using a flow cytometry machine to check the cells, using the mathematic model to fit the results into curves, judging the results. Compared with the traditional methods as plaque and immunofluorescence, the method is more correct and accurate, and is not affected by the cell state and the cell division after the infection of virus on the cells. The method has high value for the quality control and clinic application of the products.
Owner:NAT INST FOR FOOD & DRUG CONTROL

Novel coronavirus RNA nucleic acid detection quality control product and preparation method thereof

The invention provides a novel coronavirus RNA nucleic acid detection quality control product, which is used for comprehensively monitoring a COVID-19 nucleic acid detection process. The general preparation process of the novel coronavirus RNA nucleic acid detection quality control product comprises the following steps: 1) integrating COVID-19 ORF1ab and N gene fragments and performing plasmid amplification; 2) amplifying an expression system of modified phage; 3) expressing, purifying and identifying pseudovirus particles; and 4) performing quantitative detection and subpackaging. The novel coronavirus RNA nucleic acid detection quality control product provided by the invention has structural consistency with actual COVID-19 virus particles, and can truly simulate the in-vitro nucleic acid detection process of the COVID-19 virus particles, thereby realizing comprehensive monitoring of COVID-19 nucleic acid detection; and the product has the advantages of low cost, high stability, convenience in storage and transportation and the like, and is convenient for industrial-level large-scale production. In conclusion, the novel coronavirus RNA nucleic acid detection quality control product provided by the invention has important value and application prospects.
Owner:苏州艾可瑞斯生物科技有限公司

Fusion protein degradation agent and application

The invention belongs to the field of biological medicine, and relates to a fusion protein degradation agent and application thereof. The fusion protein degradation agent comprises a target protein specific binding sequence, a connector and a TRIM21 specific binding sequence which are sequentially connected, wherein the target protein specific binding sequence is a protein sequence specifically bound with a disease-related target protein; the disease-related target protein is a TRIM21 highly expressed disease-related target protein. According to the present invention, by using the characteristic that the TRIM21 simultaneously has two functions of virus elimination and immune signal transduction activation, the degradation agent capable of activating the TRIM21 is constructed, the virus-host immune interaction is simulated, the dual degradation of the disease-related target protein and the TRIM21 is induced, the TRIM21-mediated natural immune signal channel is opened, the antiviral immune response of the pathological change tissue is induced, and the TRIM 21-mediated disease-related target protein and the TRIM 21-mediated disease-related target protein can be degraded. The treatment effect of the degradation agent is enhanced.
Owner:TIANJIN MEDICAL UNIV

Method for separating virus variation sequence and separated foot-and-mouth disease virus variation sequence thereof

The invention discloses a method for separating virus variation sequence and a separated foot-and-mouth disease virus variation sequence thereof. The method of the invention firstly analyzes a reported virus variation zone and then utilizes a random peptide technology to separate and obtain a plurality of polypeptides which can stimulate virus variation; the polypeptides are used for developing vaccines, and development of vaccines can take account of virus variation, which plays a role of precaution before too late. The invention also obtains a foot-and-mouth disease variation sequence, the amino acid sequence thereof is shown as SEQ ID NO:101-200, and corresponding nucleotide sequence is shown as SEQ ID NO:1-100.The invention has simple operating method and can effectively discover a new variation sequence of the virus, which effectively secures national livestock and poultry breeding industry, develops a new way for developing broad-spectrum vaccines and also provides a new technical direction for developing bird flu vaccines, HIV vaccines and the like.
Owner:SUN YAT SEN UNIV +1

Subunit vaccine containing particle carriers and application of subunit vaccine

The invention discloses a subunit vaccine containing particle carriers and application of the subunit vaccine, and provides a novel coronavirus COVID-19 vaccine containing nano virus-like particles by taking the novel coronavirus COVID-19 vaccine as an example. According to the scheme, different nano / micron materials are used as carriers, self-assembly of subunit antigens on the carriers is achieved, and the surface structure of viruses or bacteria is fully simulated. The advantages of improving the immunogenicity, simplifying the production process and reducing the production cost are realized. Different antigen proteins are chemically covalently coupled or specifically bound and adsorbed to nano / microsphere particles with different particle sizes through physical adsorption (electrostatic interaction, hydrophobic interaction, hydrogen bonds and other specific physical effects) to form viroid particles with structures similar to those of viruses or bacteroid particles with structures similar to those of bacteria, so that the immunogenicity of the vaccine is improved.
Owner:百葵锐(深圳)生物科技有限公司

Armored RNA (Ribonucleic Acid) standard substance containing novel coronavirus ORF1ab gene, E gene and N gene and application thereof

PendingCN114277048AGood quality control performanceRealize the whole process of quality controlMicrobiological testing/measurementPeptide preparation methodsNucleic acid detectionVirusoid
The invention discloses an armored RNA (Ribonucleic Acid) standard substance containing a novel coronavirus ORF1ab gene, an E gene and an N gene. The standard substance is formed by packaging a novel coronavirus ORF1ab gene, an E gene and an N gene with capsid protein of an MS2 bacteriophage by using an MS2 bacteriophage armored RNA technology, and the prepared standard substance has the characteristics of stability, no biological infectivity, capability of truly simulating a virion structure, RNase resistance and the like, and can be used for preparing the standard substance. The method is suitable for the quality control of a nucleic acid detection method taking the ORF1ab gene, the E gene and the N gene as targets for the new coronavirus, and the evaluation of detection reagents and laboratory ability.
Owner:中国海关科学技术研究中心

Pig epidemic prevention and control flow regulation system and method based on big data

The invention discloses a live pig epidemic prevention and control flow regulation system and method based on big data, and relates to the technical field of animal health information, and the method comprises the steps: recognizing abnormal live pig signals and track intersection features of structured epidemic prevention feature data through an intelligent algorithm, comparing the virus gene difference degree, constructing a virus propagation network diagram, and carrying out the analysis of the virus propagation network diagram; outputting a high-risk propagation node map; constructing an aerosol dynamics three-dimensional space model by taking a super propagation hub node of the high-risk propagation node map as an original point and combining culture environment parameters, simulating a virus air diffusion path, and generating an environment propagation thermal distribution map; fusing the high-risk propagation node map and the environment propagation thermal distribution map, identifying a cross infection area through a multi-dimensional risk superposition model to perform risk dynamic grading, and outputting a grading early warning report; according to the invention, breakthrough improvement of the live pig epidemic prevention and control capability is realized, key nodes and potential risk areas of epidemic propagation can be accurately identified, and the pertinence of prevention and control measures is improved.
Owner:JIANGSU SHUNHE AGRI DEV CO LTD

Virus monitoring and early warning method based on deep analysis of network traffic

ActiveCN119583215Aget rid of dependenceAccurately identify hidden behaviorsSecuring communicationVirusoidInternet traffic
The invention relates to the technical field of network security, and discloses a virus monitoring and early warning method based on network traffic deep analysis, which comprises the following steps: collecting network traffic data in real time through a deep packet inspection technology, extracting traffic features, and constructing a traffic feature sequence based on a time window; establishing an anomaly detection model based on the traffic feature sequence, and identifying an anomaly mode deviating from normal behavior distribution; according to an abnormal behavior detection result, constructing a dynamic model of an equipment infection state, and quantifying an equipment infection risk; and constructing a propagation graph model in combination with an equipment interaction relationship, and simulating a diffusion path and a propagation trend of the virus in the network based on propagation dynamics. According to the method, hidden behaviors of unknown viruses and variant viruses can be accurately monitored, a virus propagation path and an influence range are dynamically predicted, optimal allocation of defense resources is realized in combination with a game theory and linear programming, and the real-time performance of virus monitoring and defense is improved.
Owner:BEIJING EASYNETWORKS TECHNOLOGY CO LTD

Detection kit for SARS-CoV-2 neutralizing antibody and application of detection kit

The invention relates to the field of antibody detection, and particularly provides a detection kit for an SARS-CoV-2 neutralizing antibody and application of the detection kit. According to the detection kit, a competition method is used for detecting the SARS-CoV-2 neutralizing antibody, two antigens of SARS-CoV-2 RBD protein and NTD protein are simultaneously applied to simulate action sites during virus infection, the neutralizing antibody can competitively block combination of ACE2 receptor protein and AXL receptor protein with the action sites, and therefore the neutralizing antibody is detected.
Owner:ZHUHAI LIVZON DIAGNOSTICS

SARS-cov-2 neutralizing antibody detection kit and its application

The invention relates to the field of antibody detection, in particular, it provides a detection kit for neutralizing antibodies against SARS‑CoV‑2 and its application. The detection kit uses a competition method to detect neutralizing antibodies against SARS-CoV-2. By simultaneously applying two antigens of SARS-CoV-2 RBD protein and NTD protein to simulate the action sites of virus infection, the neutralizing antibodies can compete Block the binding of ACE2 receptor protein and AXL receptor protein to the action site, so as to realize the detection of neutralizing antibodies.
Owner:ZHUHAI LIVZON DIAGNOSTICS

Gene sequence representation learning method based on virus propagation network

The invention discloses a gene sequence representation learning method based on a virus propagation network. The method comprises the following steps: coding a virus gene sequence, and inputting a sequence code into a hidden layer with a specific length to obtain dimensionality reduction embedding; extracting a neighbor node set with high association degree with each node in the virus propagation network, and acquiring topological information of the nodes from the virus propagation network; respectively aggregating graph context node information of the nodes by using a forward LSTM and a reverse LSTM; aggregating sequence information of neighbor nodes by using an attention mechanism to obtain a new expression of a target node gene sequence; and carrying out model training and target optimization on the gene sequence representation model by taking graph context loss as a loss function. Experiments carried out on a simulated virus transmission network, a real Australian new coronal virus transmission network and a real AIDS virus transmission network verify the effectiveness and high efficiency of the method.
Owner:NAT UNIV OF DEFENSE TECH

Novel coronavirus neutralizing antibody determination kit

The invention relates to a novel coronavirus neutralizing antibody determination kit, and belongs to the technical field of chemiluminiscence in-vitro diagnosis. The novel coronavirus neutralizing antibody determination kit comprises an R1 reagent which is streptavidin magnetic particles, an R2 reagent which is a novel coronavirus S protein RBD labeled by a chemiluminescent substance, an acridinium ester or an acridinium ester derivative is the chemiluminescent substance, and an R3 reagent is ACE2 labeled by biotin, a calibration product and a quality control product. The kit provided by the invention adopts a competition method to detect the novel coronavirus neutralizing antibody, the interaction between the virus and the host is simulated through the interaction between RBD protein and hACE2 protein, and the detection result can completely represent the result of the novel coronavirus neutralizing antibody. The kit provided by the invention adopts a direct chemiluminescence method for detection, has the advantages of low cost, no radioactive contamination, few reagent types, convenience in transportation, simplicity in operation and high detection speed, and can meet the large-scale clinical sample detection requirements of hospitals.
Owner:DIRUI MEDICAL TECH CO LTD

Preparation method of HIV-1 nucleic acid detection quality control product based on influenza virus vector

The invention provides a preparation method of an HIV-1 nucleic acid detection quality control product based on an influenza virus vector. The quality control product is obtained by performing multiplication culture, inactivation and purification on a recombinant influenza virus carrying an HIV-1 conservative gene. The preparation method of the HIV-1 nucleic acid detection quality control productbased on the influenza virus vector comprises the following steps: (1) constructing a CRISPR-Cas9 large fragment knock-in system which is inserted into an HIV-1 conservative gene and can be used for saving influenza viruses PR8; (2) co-transfecting 293T cells with the constructed system, PR8 influenza viruses PB1, PB2, PA, HA, NP, NA and M protein encoding plasmids, and exciting functions to saveinfluenza viruses, so as to obtain recombinant influenza viruses with HIV-15-'UTR; and (3) performing multiplication culture, inactivation and purification on the constructed influenza virus to obtainthe HIV-1 nucleic acid detection quality control product. The kit has the characteristic of highly simulating the HIV-1 virus, and can perform comprehensive detection on HIV-1 nucleic acid detection;The whole preparation process is simple and convenient, and the HIV-1 nucleic acid detection quality control product is low in cost and easy to store and transport, and has a good application prospect.
Owner:苏州艾可瑞斯生物科技有限公司

Simulated virus inactivation test method and system in high-speed train passenger room

The invention discloses a simulated virus inactivation test method and system in a high-speed train passenger room. The simulated virus inactivation test method in the high-speed train passenger roomcomprises the following steps: preparing a target bacteriophage suspension and diluting the target bacteriophage suspension into an aerosol generating solution; taking aerial fog generating liquid togenerate bacteriophage aerosol in a guest room; sampling the air in the guest room to obtain the total bacterial count S1 of the target bacteriophage in unit volume; filtering and sterilizing air in the guest room; sampling the filtered and sterilized air to obtain the total bacterial count S2 of the target bacteriophage in unit volume; and obtaining the inactivation rate [rho]. According to the invention, virus inactivation sampling is carried out on filtered and sterilized air in a high-speed train passenger room through adoption of the test method, so that the virus inactivation effect is evaluated, scientific guidance can be provided for research of an air purification control strategy in the train passenger room in a virus-containing micellar environment, the risk that passengers areinfected by high-risk viruses is reduced, and the public health safety level of the environment in the high-speed train passenger room is improved.
Owner:CENT SOUTH UNIV

Transmembrane peptide modified pseudovirus gene vector system

The invention relates to a film-through polypeptide modified virus imitation gene carrier system in the field of biology technology. It adopts nanometer particle which is formed by high molecular material with film-through polypeptide modified kation to prepare for the virus imitation gene carrier system. It uses the mode of admixing the virus imitation surface and the polypeptide modified non-virus carrier and simulating the virus to enters into the cell to improve the gene transmitting effect.
Owner:FUDAN UNIV

Biomimetic mineralized nanoparticles as well as preparation method and application thereof

The invention discloses biomimetic mineralized nanoparticles as well as a preparation method and application thereof. The surface of the biomimetic mineralized nanoparticle is a mineralized virus shell, virus infection can be simulated, cell uptake can be enhanced, a specific antibody for recognizing target protein can be effectively encapsulated, and meanwhile, a virus membrane component can induce expression of TRIM family protein in cells. After the biomimetic mineralized nanoparticles are taken into cells, the antibody released by the biomimetic mineralized nanoparticles can bind to the target protein and bind to the TRIM family protein to mediate degradation of the target protein. In this process, although the TRIM family protein is continuously consumed, the TRIM family protein can be compensated by the TRIM family protein endogenous expression induced by the particle of the present invention, thereby maintaining efficient degradation.
Owner:PEKING UNIV

Method, apparatus, medium and device for simulating virus mutation and infection based on quantum computing

The present invention provides a method, device, medium and equipment for simulating virus mutation and infection based on quantum computing, which relates to the technical field of quantum computing. The method assigns quantum bits and rotation angles to each base pair of the virus and the host, and establishes a quantum circuit according to the required number of quantum bits; applies a Hadamard gate to the quantum bits to put the quantum bits in a superposition state; applies a U gate to the quantum bits in the superposition state to perform a characteristic comparison of the base pair rotation angles. If there are identical base pairs in the base pair sequences of the virus and the host, a CNOT gate is applied to the quantum bits representing the base pair; a measurement operation is applied to the quantum bits of the quantum circuit, and the infection probability is obtained by analyzing the count of the quantum bits with the state of 0 in the measurement results. Applying the present invention can simulate virus mutation and infection, and the simulation results are helpful for the treatment of virus-related diseases and the development of vaccines.
Owner:QUDOOR TECH INC +1

Preparation and application of BoHV-1 virion simulated by dextran magnetic beads

The invention discloses a preparation method of BoHV-1 virus particles simulated by dextran magnetic beads. The preparation method comprises the following steps: S1, synthesizing bovine herpes virus gB, gC and gD protein genes; s2, constructing eukaryotic expression recombinant plasmids; s3, transfecting MDBK cells with eukaryotic expression plasmids; s5, eukaryotic expression protein purity; and S7, preparation of BoHV-1 virus particles simulated by the dextran magnetic beads. According to the preparation and application of the dextran magnetic bead simulated BoHV-1 virion, envelope protein is fixed on the surface of the dextran magnetic bead to prepare a subunit vaccine which is small in particle size and has almost complete antigenicity of BoHV-1, and meanwhile, the existence time of protein in a body can be prolonged through PEGylation, so that the protein can be used for simulating the BoHV-1 virion. And the immune response duration is prolonged.
Owner:QINGDAO AGRI UNIV +2

Organ chip and application thereof

The invention belongs to the technical field of tissue engineering, and particularly relates to an organ chip and application thereof. The organ chip comprises a first functional layer, a second functional layer, a third functional layer and a fourth functional layer, the first functional layer, the second functional layer, the third functional layer and the fourth functional layer are sequentially combined from top to bottom. The invention provides a method for establishing a model which is based on an organ chip and can be used for simulating transmission and action of viruses in a human body after the viruses enter the human body through air, and the structure and the function of a normal or diseased organ level are simulated by combining simulation of in-vivo circulating strain (i.e., wriggle-like movement) and the like. And the transmission and action of the virus in the human body after the virus enters the human body can be better simulated.
Owner:SUN YAT SEN UNIV

Construction and application of a research model of hbv cccDNA-host interaction

The invention belongs to the technical field of bioengineering, and particularly relates to construction and application of a model for researching interaction between HBV cccDNA and a host. The invention provides the construction and the application of the minicircle DNA model highly simulating hepatitis B virus genome cccDNA. By constructing a pmini-MC-HBV-Intron plasmid, a high-purity MC-HBV minicircle plasmid is obtained in vitro; and by optimizing a chimeric intron sequence and a secondary structure of RNA, efficient and variable splicing of the chimeric intron on the RNA level is achieved, and the MC-HBV capable of being copied at a high level in vitro is obtained. The MC-HBV can highly simulate the physiological activity between an HBV virus and host cells. The invention further discloses an in-vitro marker MC-HBV model and a detection technology, and provides the excellent model for revealing the interaction relationship between the HBV cccDNA and the host, and a function regulation mechanism, and exploring a new HBV treatment target.
Owner:SHANDONG UNIV

Cytosine nucleoside compound based on glycine, preparation method and application thereof, and bactericidal and antiviral composition

PendingCN119080854AInhibit synthesisStrong antiviral activityBiocideSugar derivativesPlant virusCytimidine
The invention provides a glycine-based cytosine nucleoside compound, a preparation method and application thereof, and a bactericidal and antiviral composition, and belongs to the technical field of medicinal chemistry. According to the cytosine nucleoside compound provided by the invention, glycine is introduced into a cytosine nucleoside leading structure, and a novel efficient candidate compound is provided for creation of novel pesticides. The RNA-dependent RNA polymerase (RdRp) of plant viruses is a key enzyme in the virus replication process, and is an important target for designing and synthesizing antiviral compounds. Bacteriostatic activity and antiviral activity results show that the cytosine nucleoside compound serving as a nucleoside analogue is combined with an active site of RdRp enzyme by simulating a CTP (cytidine triphosphate) substrate of virus RNA (ribonucleic acid), so that synthesis of the virus RNA is inhibited, and remarkable antiviral activity is shown.
Owner:SHENYANG AGRI UNIV

Enzymatic RNA Capping Method

Provided herein is a method for efficiently capping RNA in vitro. In some embodiments the capping reaction may be done at high temperature using Vaccinia capping enzyme or a variant thereof. In other embodiments, the capping reactions may comprise a capping enzyme from a large virus of amoeba, e.g., Faustovirus, mimivirus or moumouvirus, or a variant thereof. Compositions and kits for practicing the method are also provided.
Owner:NEW ENGLAND BIOLABS INC

Methods and kits for quantifying the removal of mock virus particles from a purified solution

The present invention relates to a method of quantifying the amount of Mock Virus Particles (MVP) removed from a solution as a result of processing that solution through a purification technique. This method involves the steps of adding MVP to a solution, processing the solution through a purification technique, quantifying the amount of MVP removed from the solution. The present invention also relates to a kit that can be used in conjunction with the method. This kit will comprise at least one stock solution of MVP and at least one quantification solution.
Owner:CYGNUS TECHNOLOGIES LLC

Virus monitoring and early warning method based on deep analysis of network traffic

The present invention relates to the field of network security technology, and discloses a virus monitoring and early warning method based on deep analysis of network traffic, including the following steps: collecting network traffic data in real time through deep packet detection technology, extracting traffic features, and constructing a traffic feature sequence based on a time window; establishing an anomaly detection model based on the traffic feature sequence to identify abnormal patterns that deviate from normal behavior distribution; constructing a dynamic model of the device infection state based on the abnormal behavior detection results to quantify the risk of device infection; constructing a propagation graph model in combination with the device interaction relationship, and simulating the virus diffusion path and propagation trend in the network based on propagation dynamics. The present invention can accurately monitor the hidden behaviors of unknown viruses and mutant viruses, dynamically predict the virus propagation path and impact range, and at the same time combine game theory and linear programming to achieve the optimal allocation of defense resources, thereby improving the real-time nature of virus monitoring and defense.
Owner:BEIJING EASYNETWORKS TECHNOLOGY CO LTD

SARS-CoV-2 neutralizing antibody kit and application thereof

The invention provides a flow-based SARS-CoV-2 neutralizing antibody kit and application thereof, and belongs to the field of biomedical detection. According to the present invention, the ACE2 receptor of the cell is simulated by coating the SARS-CoV-2 receptor ACE2 protein on the fluorescent microspheres, the virus infection is simulated by using the affinity of the trimer RBD protein and the ACE2, and the neutralizing antibody amount in the sample is quantitatively detected by determining the efficiency of the neutralizing antibody for inhibiting the combination of the ACE2 and the trimer RBD; therefore, the method can be used for judging the expression level of the neutralizing antibody after vaccination and evaluating the protective force of the vaccine.
Owner:章文医药(北京)有限公司

Dengue virus armored RNA standard substance, and preparation method and application thereof

The application discloses a dengue virus armored RNA standard substance and a preparation method and application thereof, and belongs to the technical field of virus detection. The dengue virus armored RNA standard substance comprises a virus-like particle shell formed by self-assembly of capsid proteins of phage MS2 and an internal encapsulated dengue virus 3' untranslated region partial sequence fragment; and the nucleotide sequence of the dengue virus 3' untranslated region partial sequence fragment is shown as SEQ ID NO: 2. The dengue virus armored RNA standard substance provided by the application can be used for nucleic acid detection of dengue virus with the dengue virus 3' untranslated region partial sequence as a target. The standard substance has the characteristics of stable property, no biological pollution, true simulation of virus particle structure and RNase resistance, and is suitable for quality control of nucleic acid detection methods with the dengue virus (type 1-4) 3' untranslated region as a target, and evaluation of detection reagents and laboratory capacity.
Owner:SCIENCE & TECHNOLOGY RESEARCH CENTER OF CHINA CUSTOMS

Dengue virus armored RNA (Ribonucleic Acid) standard substance as well as preparation method and application thereof

The invention discloses a dengue virus armored RNA (Ribonucleic Acid) standard substance as well as a preparation method and application thereof, and belongs to the technical field of virus detection. The dengue virus armored RNA standard substance comprises a virus-like particle shell formed by self-assembly of capsid protein of phage MS2 and a dengue virus 3'untranslated region partial sequence fragment entrapped in the virus-like particle shell; the nucleotide sequence of the partial sequence fragment of the 3'untranslated region of the dengue virus is as shown in SEQ ID NO: 2. The dengue virus armored RNA standard substance provided by the invention can be used for nucleic acid detection of the dengue virus taking partial sequence of the 3'untranslated region of the dengue virus as a target, and has the characteristics of stable property, no biological pollution, capability of truly simulating a virion structure and RNase resistance; the method is suitable for quality control of a nucleic acid detection method taking the dengue virus (1-4) 3'untranslated region as a target, and evaluation of detection reagents and laboratory ability.
Owner:SCIENCE & TECHNOLOGY RESEARCH CENTER OF CHINA CUSTOMS

Enzymatic RNA capping method

To provide a method for efficiently capping RNA in vitro.SOLUTION: In some embodiments, the capping reaction can be done at high temperature using Vaccinia capping enzyme or variants thereof. In other embodiments, the capping reaction may comprise capping enzymes from amoebic large viruses, such as Faust, Mimivirus, or Moumouvirus, or variants thereof. Compositions and kits for practicing the methods are also provided.SELECTED DRAWING: None
Owner:NEW ENGLAND BIOLABS INC

Antigen targeting peptide nano-micelle and application thereof

The invention discloses an antigen targeting peptide nano-micelle and application thereof, belongs to the field of biological medicine, and particularly relates to an antigen targeting peptide molecule which is composed of polyethylene glycol as a hydrophilic component and a hydrophobic region containing a matrix metalloproteinase-2 restriction site, preS1 antigen peptide and low-pH insertion peptide. The antigen targeting peptide nano-micelle is prepared from antigen targeting peptide molecules through a self-assembly technology. The antigen targeting peptide nano-micelle disclosed by the invention has accurate tumor microenvironment responsiveness, antigen peptide can be released in TME, and a preS1 epitope is anchored to a tumor cell membrane through pHLIP, so that a virus mechanism is simulated. According to the present invention, the tumor immune microenvironment can be remodeled, and the tumor cells can be induced to display the virus antigen peptide so as to activate the pre-existing anti-virus immune reaction, such that the antibody-mediated tumor cell killing can be achieved.
Owner:ZHEJIANG CANCER HOSPITAL